NEWS

Trade

AmCham Executives Gather in Israel for Annual Conference

Business

Category: Trade

On October 14-17, executives from 33 AmChams in Europe gathered in Tel Aviv, Israel for the annual European conference, devoted to the sharing of best practices and knowledge exchange.   During the conference, AmCham executives shared best practices within the areas of Member Retention and Acquisition, Governance, Communications, Committee Management and Staff Management / KPI’s. […]

Source: AmCham Denmark


More

Boyden Insights: A Big Buy for Big Blue

Business

Category: Financial / Investment

IBM has agreed to acquire the North Carolina-based cloud software firm for $34 billion. The tech pioneer, founded more than 100 years ago, is looking to transition beyond its legacy hardware and consulting business. CEO Ginni Rometty is especially keen to broaden subscription-based software offerings. IBM has seen years of declines both in software sales […]

Source: Boyden


More

Norway wealth fund calls for independence, expertise on company boards

Category: Business News

Norway’s $970-billion sovereign wealth fund, the world’s largest, will ask the 9,000 companies in which it invests to ensure their board members have sufficient independence and expertise, it said in a series of policy papers on Friday. Directors should also ensure they have sufficient time to fulfil their obligations on the boards which they serve, […]

Source: Reuters


More

Norway Stays the Course for Another Rate Increase in Early 2019

Business

Category: Financial / Investment

Norway’s central bank kept its key interest rate unchanged and reiterated its intention to tighten again early next year as policy makers proceed cautiously in unwinding the record stimulus unleashed over the past years. Norges Bank on Thursday held its benchmark at 0.75 percent, as anticipated by all analysts surveyed by Bloomberg. The krone traded […]

Source: Bloomberg


More

Konkurransetilsynet: Hemmelighold gir mer medisin for pengene

Business

Category: Government

Ut fra et konkurransefaglig ståsted er det flere momenter som taler for at hemmelighold er til det beste for pasientene. Av Kurt Brekke, sjeføkonom i Konkurransetilsynet. Det har vært mye debatt om hemmelige priser på legemidler etter at BT i slutten av april skrev om at myndighetene bestemte at medisinkjøp til 20 milliarder kroner kan […]

Source: Konkurransetilsynet


More
Page 7 of 22
1 4 5 6 7 8 9 10 22